Stonebranch Launches Robi AI to Advance Intelligent Automation and Orchestration Across Hybrid IT Environments
15.4.2026 16:00:00 EEST | Business Wire | Press release
Stonebranch, a leading provider of service orchestration and automation solutions, today announced the launch of Robi AI, an advanced artificial intelligence engine within Universal Automation Center (UAC).
As organizations scale automation across cloud, on-premises, and containerized infrastructures, they face increasing complexity in managing workflows, troubleshooting issues, and enabling broader teams to participate in automation initiatives. Robi AI addresses these challenges by introducing AI-powered intelligence directly into the automation lifecycle — with built-in governance and guardrails — helping enterprises design, manage, and optimize automation faster and more effectively.
Bringing AI-Powered Intelligence to IT Orchestration
Robi AI enhances Stonebranch UAC by delivering real-time insights, guided recommendations, and natural language interaction across automation processes. By embedding AI into orchestration workflows, organizations can reduce manual effort, improve accuracy, and accelerate time-to-value.
“Today’s enterprises require more than automation — they need intelligent orchestration that can adapt to dynamic environments,” said Giuseppe Damiani, CEO of Stonebranch. “With Robi AI, we deliver AI-driven capabilities that help teams design workflows faster, resolve issues proactively, and scale operations across the enterprise with confidence.”
Key Features of Robi AI
- AI-Powered Troubleshooting and Remediation: Perform instant root-cause analysis and receive actionable recommendations or automated remediation with the new “analyze now” feature.
- Put AI Inside Your Automation Workflows: Embed AI tasks directly into workflows, moving from rule-based automation to adaptive, intelligent systems that can handle unstructured data and make decisions with minimal human intervention.
- AI Interoperability and Self-Service: With the new MCP client/server,enable users to interact with UAC from LLM platforms such as ChatGPT, Gemini, and Claude.
- Accelerate Onboarding and Adoption with Conversational AI: Use natural language to interact with a chat-based knowledge assistant to ask “how-to” questions, trigger workflows, query status, and perform operational actions, including cancel, force-finish, and rerun — all without scripting.
Architected with a Focus on Governance, Security, Privacy, and Flexibility
- AI Governance and Guardrails: Robi AI delivers intelligent capabilities inside a structured, policy-driven control framework.
- Private and Secure by Design: Every customer has their own instance of Robi AI. Your data is private and secure, and Stonebranch does not use customer data for training purposes.
- Flexibility to Fit Your Rules: Maintain full control over AI features with a policy-driven framework designed for model flexibility. Turn features on or off, govern usage, restrict actions by role or environment, and deploy in SaaS or self-managed environments.
Embedding Intelligence into the Automation Lifecycle
Robi AI brings AI-powered capabilities directly into the enterprise’s orchestration layer — enhancing how workflows are created, executed, and optimized. From AI-assisted development and real-time troubleshooting to embedded AI tasks within workflows, organizations can reduce complexity, accelerate issue resolution, and extend automation to new use cases. All AI-driven actions operate within a governed, policy-driven framework, ensuring predictable outcomes, compliance, and full control over how AI is applied across the enterprise.
Availability
Robi AI is available in Stonebranch Universal Automation Center (UAC) version 8.0. Explore the links below to learn more.
About Stonebranch
Stonebranch builds IT orchestration and automation solutions that transform business IT environments from simple IT task automation into sophisticated, real-time business service automation. No matter the degree of automation, the Stonebranch platform is simple, modern, and secure. Using Stonebranch Universal Automation Center, enterprises can seamlessly orchestrate workloads and data across technology ecosystems and silos. Headquartered in Atlanta, Georgia, with points of contact and support throughout the Americas, Europe, and Asia, Stonebranch serves some of the world’s largest financial, manufacturing, healthcare, travel, transportation, energy, and technology institutions.
View source version on businesswire.com: https://www.businesswire.com/news/home/20260415332049/en/
Contacts
Scott Davis
Chief Marketing Officer, Stonebranch
scott.davis@stonebranch.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
www.businesswire.com

Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Imagine Dragons to Perform at Abu Dhabi Grand Prix21.5.2026 18:51:00 EEST | Press release
Ethara, organiser of the Formula 1 Etihad Airways Abu Dhabi Grand Prix, have announced that one of the world’s biggest bands, Imagine Dragons, will headline the Saturday After-Race Concerts at the F1 Season Finale in Abu Dhabi. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521214839/en/ Imagine Dragons to perform at Formula 1 Etihad Airways Abu Dhabi Grand Prix (Photo: AETOSWire) The announcement is another landmark moment for the Abu Dhabi Grand Prix, whose thrilling Yasalam presented by e& fan entertainment offering has become synonymous with the F1 Championship finale in Abu Dhabi and is recognised as one of the most compelling sports and entertainment crossovers globally. The global chart-toppers join Lewis Capaldi and Zara Larsson, who are set to kick off a blockbuster line-up of performances on Yas Island on Thursday, 3 December, with more major international artists to be revealed. With their popular top hits, Ima
Otovo Hits 30,000 Customers in Under a Year, Tackling the Growing ‘Solar Service Crisis’21.5.2026 17:25:00 EEST | Press release
Otovo ASA (“Otovo”), a leading global energy service provider for residential and commercial customers, today announced it has reached 30,000 customers across the U.S. and Europe. A total of 20,000 customers have enrolled in Otovo Care, the Company’s membership-based home and commercial energy service, which is powered by Otovo’s industry-leading AI platform, Endurance™. “Reaching 30,000 customers in less than year is proof positive that home and business owners value their power systems,” said William J. (John) Berger, CEO of Otovo. “The ‘solar service crisis’ that is leaving millions of orphaned energy systems without support is driving strong interest in our Otovo Care membership program. Every day your home or commercial power system is not working, you are throwing money away. Otovo’s rapid response service platform keeps you up and running, ensuring your investment is delivering.” The rapid growth of the residential solar market created a growing population of “orphaned” solar sy
Carnegie Mellon University and Cleveland Clinic Develop AI System to Interpret Cardiac MRI Scans with Enhanced Accuracy21.5.2026 15:05:00 EEST | Press release
A team of researchers from Carnegie Mellon University, in collaboration with Cleveland Clinic’s Cardiovascular Innovation Research Center, has developed an artificial intelligence (AI) system capable of interpreting some of the most complex heart scans in medicine, cardiac magnetic resonance imaging (MRI), without the need for manually labeled training data. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521762286/en/ A team of researchers from Carnegie Mellon University, in collaboration with Cleveland Clinic’s Cardiovascular Innovation Research Center, has developed an artificial intelligence (AI) system capable of interpreting some of the most complex heart scans in medicine, cardiac magnetic resonance imaging (MRI), without the need for manually labeled training data. The novel system, called CMR-CLIP, is designed to interpret cardiac MRI scans by connecting moving images of the heart with corresponding clinical radio
The Live Moment Effect: Genius Sports and MediaScience Study Finds Specific Moments in Live Sports Can Double Unaided Brand Recall21.5.2026 15:00:00 EEST | Press release
Genius Sports Limited (NYSE: GENI), a global leader in real-time sports data, today released new biometric research conducted with MediaScience showing that ads delivered immediately after emotionally heightened moments in live sports can double unaided brand recall. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521475265/en/ The Live Moment Effect report from Genius Sports and MediaScience. The study, The Live Moment Effect, finds that advertising effectiveness is significantly influenced by a viewer’s emotional state immediately before an ad is shown. In controlled biometric testing, ads shown after high-intensity sporting moments, such as near-scoring plays or crucial momentum shifts, delivered approximately double the unaided brand recall of baseline conditions. The Moment Before the Ad Matters The research challenges long-held assumptions about media value, showing that not all impressions are equal. Live sports rem
Merck Announces First Patient Dosed in Phase 3 Study for Investigational Antibody-Drug Conjugate in Colorectal Cancer21.5.2026 15:00:00 EEST | Press release
Merck, a leading science and technology company, today announced that the first patient has been dosed in the Phase 3 PROCEADE®-CRC-03 trial (NCT07549412). The study is evaluating precemtabart tocentecan (Precem‑TcT), a potential first‑in‑class investigational anti‑CEACAM5 antibody‑drug conjugate (ADC), for the treatment of metastatic colorectal cancer (mCRC). “Leveraging our novel payload‑linker technology, Precem‑TcT is the first CEACAM5‑targeted ADC in clinical studies with an exatecan payload, rationally designed for stability and enhanced cancer cell killing activity,” said David Weinreich, MD, MBA, Global Head of R&D and Chief Medical Officer for the Healthcare business of Merck. “The Phase 3 study and the enrollment of the first patient with Precem-TcT build on the Company’s more than 20 years of expertise in colorectal cancer, and highlight our commitment to advancing differentiated ADCs for heavily pretreated patients with limited treatment options.” The PROCEADE®-CRC-03 study
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom